Scotiabank raised the firm’s price target on Andlauer Healthcare (ANDHF) to C$55 from C$43 and keeps a Sector Perform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
- Andlauer Healthcare downgraded to Sell from Buy at TD Securities
- UPS to Acquire Andlauer Healthcare Group in C$2.2 Billion Deal
- UPS to acquire Andlauer Healthcare for $1.6B
- Andlauer Healthcare price target lowered to C$43 from C$44.50 at Scotiabank
- Andlauer Healthcare Group Declares First Quarter Dividend